Jeff Geschwind, MD: Cancer Drug Innovator Founder of Cage Pharma, Jeff Geschwind, MD, focuses on targeting tumor metabolism to develop novel cancer drugs. His research on glycolysis inhibition offers new hope for aggressive cancers. https://www.linkedin.com/in/jeff-geschwind-037200174